Altroconsumo: Brand drug for generics. (2020). https://choosingwiseLYITALY.ORG/wp-content/Uploads/2020/03/UNWARRANTED-DISTRUST-OF-GENERIC-DRUGS.PDF
Andersson, K., Bergström, G., Petzold, Mg, Carlsten, A. Health policy 81(2–3), 376–384 (2007)
Google Academic Search
Attitudes and purchases for Arcaro, R., Veiga, CRP, DA Silva, WV, Pereira da Veiga, C.: General Drugs. int. J. Environment. Coastal air hygiene 18(9), 4579 (2021)
Google Academic Search
Belloni, A., Morgan, D., Paris, V.: Pharmaceutical Expenses and Policy: Past trend and future challenge. OECD Health Work Paper (2016)
Bried, M., Dad, M., Genovese, U., Locatels, F., PL, PL, F., F. Autoid One. rotation. 14(6), 543–546 (2015)
Blomqvist, a. : Double agent doctors: information asymmetry, health insurance and medical care. J. Health Econ. 10(4), 411–432 (1991)
Burkhard, D., Schmid, CPR, Wüthrich, K.: Financial Insentive and Doctor prescription behavior: Evidence of distribution regulations. Health economy. 28(9), 1114–1129 (2019)
Google Academic Search
Callaway, b. : Differences for policy evaluation. Labor, personnel and population economy handbook, PP. 1–61 (2023)
Cattaneo, MD, IDROBO, N., Titiunik, R.: Practical introduction to regression discontinuance: Expansion. Cambridge University Press (2024)
Colombo, GL, Agabiti-Rosei, E., Margonato, A., Mencacci, C., Montecucco, CM, Trevisan, R. Vision -type branded drugs: Retrospectary data in five regional health care units in Lombardia, Italy. plos one 8(12), E82990 (2013)
Google Academic Search
Crea, G., Galizzi, MM, Linnosmaa, I., Miraldo, M.: Doctor Itaism and Moral Risk: (No) Evidence of Finland’s prescription data. J. Health Econ. 65153–169 (2019)
Google Academic Search
Currie, J., Li, A., Schnell, M.: Influence of competition on prescriptions. Technology Report, National Economic Research Bureau (2023)
European Commission: European Pharmaceutical Strategy. https://eur-rex.europa.eu/legal-content/en/txt/pdf/?uri=Celex:520220dc0761. The Committee on the European Council, Committee, European Economic and Social Council and Regional Committee, COM (2020) 761 FINAL (2020)
Ferrándiz, JM: The influence of general products in the pharmaceutical industry. Health economy. 8(7), 599–612 (1999)
Google Academic Search
Ferre, F., Giulio de Belvis, A., Valerio, L., Longhi, S., Lazzari, A., Factor, G., Ricciardi, W., MareSSO, A.: Italy: Health Systems Review (Health System of Transition 16) (2014)
Gersen, JE, POSNER, EA: Soft Act: Lessons for Congress. Stan. L. Rev. 61573 (2008)
Google Academic Search
Goldberg, T., Devito, CA, Smith, D. Med. care 17(4), 411–419 (1979)
Granlund, D.: Is your personal doctor more commonly replaced by prescribed medicines? Social Sci -fi science. Med. 69(11), 1643–1650 (2009)
Google Academic Search
Griffin, Ba, Schuler, MS, PANE, J., Patrick, SW, Smart, R., Stein, BD, Grimm, G., Stuart, EA: How to estimate the policy effect in the context of joint generation policies. Health service. Results res. Method. 23(2), 149–165 (2023)
Google Academic Search
Gutiérrez-Valencia, M., Martínez-Velilla, N., Vilches-Moraga, A. EUR. Geriat. Med. 10(1), 1–3 (2019)
Google Academic Search
Hawthorne, G., Lightfoot, CJ, Smith, AC, KHUNTI, K., Wilkinson, TJ: Multiple Reflection rate and pattern of chronic kidney disease: Observed multiple center cohort research. int. Urol. nerves. 55(8), 2047–2057 (2023)
Google Academic Search
Håkonsen, H., Wängberg, M., Alani, D., Hedenrud, T.: General Daemyung University Private Painkiller: Swedish pharmacy customer knowledge and attitude. J. Pharm. Policy practices. 1360 (2020)
Google Academic Search
Iizuka, T.: Medicine and adoption of General Pharmaceuticals. morning. Econ. rotation. 102(6), 2826–2858 (2012)
Google Academic Search
Italy Pharmaceutical Institution (AIFA): AIFA press release 24/2024. (2024). https://www.aifa.gov.it/documents/20142/2317348/comunicato_AIFA_24-2024_en.pdf. February 13, 2025 approach
ITO, Y., HARA, K., Kobayashi, Y.: The influence of inertia on brand and general drug selection. J. Econ. action. organ. 172364–379 (2020)
Google Academic Search
Jommi, C., Armeni, P., De Luca, C.: Pharmaceuticals Affects on Pharmaceutical Government and Shopping. EGEA (2011)
Kahan, DM: Soft nude vs. Hard shovel: sticky norm problem solving. U. Chi. L. Rev., pp. 607–645 (2000)
Law 122/2010: Converted into law by law, law of laws on May 31, 2010, n. 78 includes urgent measures for financial stabilization and economic competitiveness. (10g0146) (2010)
Law 27/2012: Revision of the Law of Law on January 24, 2012, N. 1: urgent measures for competition, liberalization and infrastructure. Official Government Legislation (2012)
LIU, M., YAO, L.: The impact of US general alternative methods on generic use and market competition. chemist. policy 1(1), 33–41 (2025)
Google Academic Search
Lu, S., CAI, J., XU, F.: The low price of the generic agent in China can weaken the patient’s drug awareness and compliance. Drug disc. …to 14(2), 103–104 (2020)
Google Academic Search
Pruckner, GJ, School, T.: Hospitals and famous prescription decisions in foreign patients. Health economy. 27(8), 1264–1283 (2018)
Google Academic Search
RisChatsch, M., Trottmann, M., Zweifel, P.: General alternative, financial interest and incomplete organs. int. J. Health Care Finance Econ. 13(2), 115–138 (2013)
Google Academic Search
Romanelli, RJ, SEGAL, JB: After switching from the brand to generic agent among the managers of management, statin compliance predictor. J. Gen. intern. Med. 29(10), 1372–1378 (2014)
Google Academic Search
Rome, BN, SARPATWARI, A., Kesselheim, AS: New general competition and general replacement. Value health 25(10), 1736–1742 (2022)
Google Academic Search
Samuelson, W., Zeckhauser, R.: Current status prejudice of decision making. J. Risk uncertainty. 17–59 (1988)
Google Academic Search
Saposnik, G., MAMDANI, M., Terzaghi, M., Saladino, ML, SILVA, B., tobler, PN, Caceres, F. Front. New roll. 9835 (2018)
Google Academic Search
SCHAUMANS, C.: General practitioners’ prescription behavior: competition problem. Health policy 119(4), 456–463 (2015)
Google Academic Search
Shrank, WH, Choudhry, NK, Agnew-Blais, J., Federman, Ad, Liberman, JN, Liu, J., Kesselheim, As You can lower the drug outlook for Medicaid. Health AFF. 29(7), 1383–1390 (2010)
Google Academic Search
Skaltsas, Ln, Vasileiou, KZ: Patient’s perception of Greece’s general drugs. Health policy 119(11), 1406–1414 (2015)
Google Academic Search
Skipper, N., VEJLIN, R.: Determination of general brand drug selection: Evidence of Danish data throughout the population. Social Sci -fi science. Med. 130204–115 (2015)
Google Academic Search
Skipper, N., VEJLIN, R.: Determination of general brand drug selection: Evidence of Danish data throughout the population. Social Sci -fi science. Med. 130204–115 (2015)
Google Academic Search
Song, Y., Barthol, D.: The influence of national pharmacist regulations on general replacement of prescription drugs. Health economy. 27(11), 1717–1737 (2018)
Google Academic Search
Sorenson, C., Drummond, M., bhuiyan khan, B.: Medical technology as a major driver of health expenditure: separate relationships. Clinicoecon. Results res., 223–234 (2013)
STOFFEL, ST, Spencer, R., Konya, J., VLAEV, I., Schwenkglenks, M.: Purchases in Medical Decisions: A Study on Experimental Studies to Investigate the prescription behavior of the general practitioner. plos one 19(7), E0297019 (2024)
Tang, M., Wu, Y.: Medical provider as a double agent in a universal health care system: Evidence of Taiwan’s general pharmaceutical adoption. actually. Econ. 59(1), 169–203 (2020)
Google Academic Search
Terrizzi, S., Meyerhoefer, C.: Price elasticity estimation between brand and generic drugs. contemp. Econ. policy 38(1), 94–108 (2020)
Google Academic Search
